La autofagia media la Resistencia al tratamiento con gemcitabina a través de la vía de señalización E2F1-p300-VMP1 en células tumorales pancreáticas.

ROPOLO A, MOLEJÓN MI, CATRINACIO C, RENNA F, BOGGIO V, GONZÁLEZ CD, VACCARO MI.

Buenos Aires

Congreso; Semana Panamericana de Enfermedades Digestivas; 2014

Sociedad Panamericana de Enfermedades Digestivas

<!-- /* Font Definitions */@font-face{font-family:"Cambria Math";panose-1:2 4 5 3 5 4 6 3 2 4;mso-font-charset:0;mso-generic-font-family:auto;mso-font-pitch:variable;mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face{font-family:Calibri;panose-1:2 15 5 2 2 2 4 3 2 4;mso-font-charset:0;mso-generic-font-family:auto;mso-font-pitch:variable;mso-font-signature:-536870145 1073786111 1 0 415 0;} /* Style Definitions */p.MsoNormal, li.MsoNormal, div.MsoNormal{mso-style-unhide:no;mso-style-qformat:yes;mso-style-parent:"";margin:0in;margin-bottom:.0001pt;mso-pagination:widow-orphan;mso-hyphenate:none;font-size:12.0pt;font-family:"Times New Roman";mso-fareast-font-family:"Times New Roman";mso-ansi-language:ES;mso-fareast-language:AR-SA;}.MsoChpDefault{mso-style-type:export-only;mso-default-props:yes;font-size:11.0pt;mso-ansi-font-size:11.0pt;mso-bidi-font-size:11.0pt;font-family:Calibri;mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:minor-bidi;mso-ansi-language:ES-AR;}.MsoPapDefault{mso-style-type:export-only;margin-bottom:10.0pt;line-height:115%;}@page WordSection1{size:8.5in 11.0in;margin:1.0in 1.0in 1.0in 1.0in;mso-header-margin:.5in;mso-footer-margin:.5in;mso-paper-source:0;}div.WordSection1{page:WordSection1;} /* List Definitions */@list l0{mso-list-id:716856587;mso-list-type:hybrid;mso-list-template-ids:2014723766 738852879 738852889 738852891 738852879 738852889 738852891 738852879 738852889 738852891;}@list l0:level1{mso-level-tab-stop:none;mso-level-number-position:left;margin-left:322.8pt;text-indent:-.25in;}@list l0:level2{mso-level-number-format:alpha-lower;mso-level-tab-stop:none;mso-level-number-position:left;text-indent:-.25in;}@list l0:level3{mso-level-number-format:roman-lower;mso-level-tab-stop:none;mso-level-number-position:right;text-indent:-9.0pt;}@list l0:level4{mso-level-tab-stop:none;mso-level-number-position:left;text-indent:-.25in;}@list l0:level5{mso-level-number-format:alpha-lower;mso-level-tab-stop:none;mso-level-number-position:left;text-indent:-.25in;}@list l0:level6{mso-level-number-format:roman-lower;mso-level-tab-stop:none;mso-level-number-position:right;text-indent:-9.0pt;}@list l0:level7{mso-level-tab-stop:none;mso-level-number-position:left;text-indent:-.25in;}@list l0:level8{mso-level-number-format:alpha-lower;mso-level-tab-stop:none;mso-level-number-position:left;text-indent:-.25in;}@list l0:level9{mso-level-number-format:roman-lower;mso-level-tab-stop:none;mso-level-number-position:right;text-indent:-9.0pt;}ol{margin-bottom:0in;}ul{margin-bottom:0in;}-->Laautofagia media la Resistencia al tratamiento con gemcitabina a través de lavía de señalización E2F1-p300-VMP1 en células tumorales pancreáticas. RopoloA, Molejón MI, Catrinacio C, Renna F, Boggio V, González CD, Vaccaro MI.Semana Panamericana de Enfermedades Digestivas, Buenos Aires, Argentina. 6-9Octubre 2014. Acta GastroenterológicaLatinoamericana 44(Suplemento N°1): S18, 2014.